Literature DB >> 6161299

Beta-2-microglobulin review: its relevance in clinical oncology.

E H Cooper, T Plesner.   

Abstract

Beta-2-microglobulin (beta 2-m) is an intrinsic part of the HLA system and is most probably involved in cell recognition. The levels of free beta 2-m in the blood and urine are influenced by beta 2-m production and its clearance and destruction in the kidney. Many tumors can be associated with an elevated serum beta 2-m, the reason is unknown. The most promising application of beta 2-m as a tumor marker would appear to be lymphoid malignancies, especially multiple myeloma and chronic lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161299     DOI: 10.1002/mpo.2950080403

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  23 in total

1.  Therapeutic monoclonal antibodies for multiple myeloma: an update and future perspectives.

Authors:  Jing Yang; Qing Yi
Journal:  Am J Blood Res       Date:  2011-06-15

2.  ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer.

Authors:  Jianning Sun; Zhu-Lin Yang; Xiongying Miao; Qiong Zou; Jinghe Li; Lufeng Liang; Guixiang Zeng; Senlin Chen
Journal:  J Mol Histol       Date:  2014-10-14       Impact factor: 2.611

3.  Emotional approach coping in older adults as predictor of physical and mental health.

Authors:  Michael A Hoyt; Ashley Wei-Ting Wang; Ian A Boggero; Tory A Eisenlohr-Moul; Annette L Stanton; Suzanne C Segerstrom
Journal:  Psychol Aging       Date:  2020-04-09

Review 4.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

5.  Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells.

Authors:  Bailee H Sliker; Benjamin T Goetz; Haley L Peters; Brittany J Poelaert; Gloria E O Borgstahl; Joyce C Solheim
Journal:  Cancer Biol Ther       Date:  2019-02-27       Impact factor: 4.742

6.  Task-switching ability protects against the adverse effects of pain on health: A longitudinal study of older adults.

Authors:  Ian A Boggero; Tory Eisenlohr-Moul; Suzanne C Segerstrom
Journal:  Br J Health Psychol       Date:  2015-12-20

Review 7.  Novel immunotherapies.

Authors:  Qing Yi
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

8.  Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide.

Authors:  C de Gislain; M Dumas; P d'Athis; J L Lautissier; A Escousse; J Guerrin
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Serum and tissue beta-2 microglobulin levels in patients with Helicobacter pylori infection.

Authors:  Hatice Akay; Alaattin Akay; Seyfettin Köklü
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

10.  Progressive renal insufficiency in methylmalonic acidemia.

Authors:  K H Molteni; T D Oberley; J A Wolff; A L Friedman
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.